Lundbeck counts on employee growth despite economic turmoil

Inflation, war, and supply issues have put dealing with economic risks at the top of Lundbeck’s agenda, according to the pharmaceutical firm’s chief executive, Deborah Dunsire.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Lundbeck loses head of US organization
For subscribers